Research/News - 2015

Decline in Perinatal HIV Transmission Rates 2000-2011

Apr 03, 2015

From 2000-2011, perinatal HIV transmission rates have continually declined in the United Kingdom and Ireland, reaching a low of 5 per 1,000 in 2010-2011. Earlier initiation of ART during pregnancy contributed to this decrease. Rates of transmission were lower in women... Read More

Factors Contributing to High Rates of Perinatal HIV Transmission

Apr 01, 2015

Perinatal HIV has yet to be eliminated in the United States due to a number of factors.  Researchers did a chart review to determine what factors contribute to higher rates of transmission.  As might be expected, lack of prenatal care and limited to no use of... Read More

Updated Pediatric Guidelines Available - March 2015

Mar 05, 2015

The US Public Health Service released an update to the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection on March 5, 2015.  This update can be found on the AIDSInfo site and on our website under the USPHS Perinatal Guidelines Quick Link.

Raltegravir and Pregnancy

Jan 30, 2015

Researchers looked at the pharmacokinetics of raltegravir for use as an antiretroviral during pregnancy.  Despite decreased rates of absorption during pregnancy, the drug readily crossed the placenta.  Similar decreases in rates in non pregnant adults indicates that... Read More

Meta-Analysis of Hormonal Contraception Use and HIV Risk

Jan 29, 2015

A meta-analysis of 12 studies showed an increased risk of HIV acquisition for women using Depo-Provera (depot medroxyprogesterone acetate) as birth control compared with women in the general population.  In addition, there was no increased risk for those women using oral... Read More

Next HIV-Specific Prenatal Classes Begin February 2015

Jan 29, 2015

The next series of PACPI's HIV-specific prenatal classes have been scheduled for February and March 2015.  Please see the attached flyer for the class and call 312-334-0971 to enroll your clients and patients.

Exposure In Utero to ARVs and Risk of Birth Defects

Jan 05, 2015

Researchers from the French Perinatal Cohort Study examined in utero exposure to antiretrovirals during the first trimester and whether this exposure resulted in birth defects.  Specifically, researchers determined that first trimester exposure to zidovudine resulted in... Read More